• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    1/26/22 11:01:56 AM ET
    $ALXO
    $AMAM
    $AXDX
    $BROG
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ALXO alert in real time by email

     

    During Wednesday's morning session, 34 stocks hit new 52-week lows.

    Things to Consider About Today's 52-Week Lows:

    • Illumina (NASDAQ:ILMN) was the biggest company in terms of market cap to set a new 52-week low.
    • Catalyst Biosciences (NASDAQ:CBIO) was the smallest firm by market cap to set a new 52-week low.
    • Gatos Silver (NYSE:GATO) saw the most pronounced move, as shares traded down 65.34% to hit its new 52-week low.
    • Home Plate Acquisition (NASDAQ:HPLT) saw the sharpest rebound, as shares ascended 0.1%, reversing after hiting a new 52-week low.

    Stocks that set new 52-week lows on Wednesday are as follows:

    • Illumina (NASDAQ:ILMN) shares reached a new 52-week low of $339.15 on Wednesday morning, moving up 0.23%.
    • Rollins (NYSE:ROL) shares fell to $29.34 on Wednesday, setting a new 52-week low with a shift of down 5.07%.
    • MarketAxess Holdings (NASDAQ:MKTX) shares moved down 2.1% on Wednesday to hit a new 52-week low of $333.74, drifting down 2.1%.
    • Nielsen Holdings (NYSE:NLSN) stock achieved a new 52-week low on Wednesday morning, hitting $18.14 and moving down 2.91%.
    • Boston Beer Co (NYSE:SAM) shares set a new 52-week low of $422.22. The stock traded down 2.89%.
    • iQIYI (NASDAQ:IQ) shares made a new 52-week low of $3.90 on Wednesday. The stock was down 4.02% for the day.
    • TAL Education (NYSE:TAL) shares moved down 4.46% on Wednesday to hit a new 52-week low of $2.87, drifting down 4.46%.
    • Monro (NASDAQ:MNRO) shares fell to $52.88 on Wednesday, setting a new 52-week low with a shift of down 4.65%.
    • Heska (NASDAQ:HSKA) stock set a new 52-week low of $136.02 on Wednesday, moving down 0.87%.
    • Heartland Express (NASDAQ:HTLD) shares moved down 2.82% on Wednesday to hit a new 52-week low of $14.81, drifting down 2.82%.
    • Faro Technologies (NASDAQ:FARO) shares moved up 1.67% on Wednesday to hit a new 52-week low of $54.98, drifting up 1.67%.
    • Brooge Energy (NASDAQ:BROG) shares set a new 52-week low of $7.90. The stock traded down 1.25%.
    • Khosla Ventures Acq (NASDAQ:KVSC) stock drifted down 0.2% on Wednesday morning to hit a new 52-week low of $9.66.
    • Ribbon Comms (NASDAQ:RBBN) stock dropped to a yearly low on Wednesday of $4.27. Shares traded down 0.35%.
    • ALX Oncology Holdings (NASDAQ:ALXO) stock hit $14.50 on Wednesday morning, setting a new 52-week low for a change of down 1.53%.
    • Nyxoah (NASDAQ:NYXH) stock broke to a new 52-week low of $19.02 on Wednesday. Shares of the company traded down 2.65%.
    • ECP Environmental Growth (NASDAQ:ENNV) shares made a new 52-week low of $9.35 on Wednesday. The stock was down 3.6% for the day.
    • GCM Grosvenor (NASDAQ:GCMG) shares set a new 52-week low of $9.13. The stock traded down 0.33%.
    • iClick Interactive Asia (NASDAQ:ICLK) shares set a new yearly low of $3.74 this morning. The stock was up 0.59% on the session.
    • Home Plate Acquisition (NASDAQ:HPLT) stock achieved a new 52-week low on Wednesday morning, hitting $9.65 and moving down 0.1%.
    • Gatos Silver (NYSE:GATO) stock dropped to a yearly low on Wednesday of $3.37. Shares traded down 65.34%.
    • Gracell Biotechnologies (NASDAQ:GRCL) shares fell to $3.60 on Wednesday, setting a new 52-week low with a shift of down 3.22%.
    • Accelerate Diagnostics (NASDAQ:AXDX) stock drifted down 1.3% on Wednesday morning to hit a new 52-week low of $3.39.
    • eFFECTOR Therapeutics (NASDAQ:EFTR) stock drifted up 4.98% on Wednesday morning to hit a new 52-week low of $5.20.
    • Ambrx Biopharma (NYSE:AMAM) stock drifted up 8.51% on Wednesday morning to hit a new 52-week low of $4.86.
    • Cortexyme (NASDAQ:CRTX) shares fell to $5.60 on Wednesday, setting a new 52-week low with a shift of down 28.53%.
    • 89bio (NASDAQ:ETNB) stock dropped to a yearly low on Wednesday of $8.00. Shares traded up 0.12%.
    • Yoshitsu (NASDAQ:TKLF) stock drifted down 6.63% on Wednesday morning to hit a new 52-week low of $3.53.
    • Tyme Technologies (NASDAQ:TYME) shares set a new 52-week low of $0.29. The stock traded down 30.81%.
    • E-Home Household Service (NASDAQ:EJH) stock hit $0.79 on Wednesday morning, setting a new 52-week low for a change of down 1.11%.
    • Catalyst Biosciences (NASDAQ:CBIO) shares were down 2.07% for the day, having made a 52-week low of $0.56.

     

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ALXO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALXO
    $AMAM
    $AXDX
    $BROG

    CompanyDatePrice TargetRatingAnalyst
    Ribbon Communications Inc.
    $RBBN
    2/6/2026$2.90Buy → Neutral
    B. Riley Securities
    TAL Education Group
    $TAL
    1/30/2026$18.00Neutral → Outperform
    Macquarie
    Crescent Biopharma Inc.
    $CBIO
    1/28/2026$35.00Overweight
    Piper Sandler
    Crescent Biopharma Inc.
    $CBIO
    1/21/2026$35.00Buy
    Guggenheim
    Rollins Inc.
    $ROL
    12/17/2025$72.00Equal-Weight → Overweight
    Morgan Stanley
    Rollins Inc.
    $ROL
    12/5/2025$72.00Equal Weight → Overweight
    Barclays
    MarketAxess Holdings Inc.
    $MKTX
    11/20/2025$209.00Overweight → Equal-Weight
    Morgan Stanley
    ALX Oncology Holdings Inc.
    $ALXO
    11/13/2025$4.00Buy
    Jefferies
    More analyst ratings

    $ALXO
    $AMAM
    $AXDX
    $BROG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Fitzsimmons Peter D bought $251,017 worth of shares (13,350 units at $18.80), increasing direct ownership by 16% to 99,283 units (SEC Form 4)

    4 - MONRO, INC. (0000876427) (Issuer)

    2/5/26 3:32:45 PM ET
    $MNRO
    Automotive Aftermarket
    Consumer Discretionary

    Director Goodman Corey S bought $4,999,999 worth of shares (3,184,713 units at $1.57) (SEC Form 4)

    4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)

    2/4/26 4:15:59 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EXECUTIVE CHAIRMAN EMERITUS Rollins Gary W sold $650,605 worth of shares (10,355 units at $62.83), decreasing direct ownership by 0.19% to 5,312,114 units (SEC Form 4)

    4 - ROLLINS INC (0000084839) (Issuer)

    1/30/26 3:01:46 PM ET
    $ROL
    Diversified Commercial Services
    Consumer Discretionary

    $ALXO
    $AMAM
    $AXDX
    $BROG
    SEC Filings

    View All

    MarketAxess Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - MARKETAXESS HOLDINGS INC (0001278021) (Filer)

    2/6/26 6:30:25 AM ET
    $MKTX
    Investment Bankers/Brokers/Service
    Finance

    Ribbon Communications Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Ribbon Communications Inc. (0001708055) (Filer)

    2/5/26 4:15:31 PM ET
    $RBBN
    EDP Services
    Technology

    Illumina Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ILLUMINA, INC. (0001110803) (Filer)

    2/5/26 4:09:49 PM ET
    $ILMN
    Medical Specialities
    Health Care

    $ALXO
    $AMAM
    $AXDX
    $BROG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The domestic service industry will continue to be exempt from value-added tax, and the 2026 tax reform will promote the sustainable and high-quality development of China's domestic service sector

    FUZHOU, China, Feb. 6, 2026 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider in China, announced today that the company will fully leverage new tax incentives to enhance financial management, strengthen training for domestic service personnel, improve service quality, and introduce AI technology. The company will progressively roll out a human-machine integrated service model and make effective use of tax benefits to increase staff deployment rates, propelling its performance to new heights by 2026. Key support directions for China's 2026 tax policies targeting the domestic service industry: 1. Domestic

    2/6/26 8:30:00 AM ET
    $EJH
    Other Consumer Services
    Consumer Discretionary

    MarketAxess Reports Fourth Quarter and Full Year 2025 Financial Results

    Record Revenue of $846 Million in 2025 Driven by 10% Growth in Revenue Outside U.S. Credit Products 24% Increase in Block Trading ADV to Record $5 Billion in 2025 48% Increase in Portfolio Trading ADV to Record $1.4 Billion in 2025 with Record U.S. Credit ADV & Market Share 33% Increase in Dealer-Initiated ADV in 2025 MarketAxess Holdings Inc. (NASDAQ:MKTX), the operator of a leading electronic trading platform for fixed-income securities, today announced financial results for the fourth quarter and full year ended December 31, 2025. 4Q25 select financial and operational highlights* Total revenues of $209.4 million increased 3.5%, and included an increase of approximately $1.6

    2/6/26 6:30:00 AM ET
    $MKTX
    Investment Bankers/Brokers/Service
    Finance

    Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025

    Fourth quarter 2025 results: Revenue of $1.16 billion, up 5% from Q4 2024 (up 4% on a constant currency basis)Ex-China revenue of $1.10 billion, up 8% from Q4 2024 (up 7% on a constant currency basis)GAAP operating margin of 17.4% and non-GAAP operating margin of 23.7%GAAP diluted EPS of $2.16 and non-GAAP diluted EPS of $1.35Fiscal year 2025 results: Revenue of $4.34 billion, flat compared to 2024 on both a reported and constant currency basisEx-China revenue of $4.10 billion, up 2% from 2024 on both a reported and constant currency basisGAAP operating margin of 18.6% and non-GAAP operating margin of 23.1%GAAP diluted EPS of $5.45 and non-GAAP diluted EPS of $4.84Fiscal year 2026 guidance:

    2/5/26 4:06:00 PM ET
    $ILMN
    Medical Specialities
    Health Care

    $ALXO
    $AMAM
    $AXDX
    $BROG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ribbon Communications downgraded by B. Riley Securities with a new price target

    B. Riley Securities downgraded Ribbon Communications from Buy to Neutral and set a new price target of $2.90

    2/6/26 8:10:30 AM ET
    $RBBN
    EDP Services
    Technology

    TAL Education upgraded by Macquarie with a new price target

    Macquarie upgraded TAL Education from Neutral to Outperform and set a new price target of $18.00

    1/30/26 6:41:31 AM ET
    $TAL
    Other Consumer Services
    Real Estate

    Piper Sandler initiated coverage on Crescent Biopharma with a new price target

    Piper Sandler initiated coverage of Crescent Biopharma with a rating of Overweight and set a new price target of $35.00

    1/28/26 7:10:21 AM ET
    $CBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALXO
    $AMAM
    $AXDX
    $BROG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Fitzsimmons Peter D bought $251,017 worth of shares (13,350 units at $18.80), increasing direct ownership by 16% to 99,283 units (SEC Form 4)

    4 - MONRO, INC. (0000876427) (Issuer)

    2/5/26 3:32:45 PM ET
    $MNRO
    Automotive Aftermarket
    Consumer Discretionary

    Director Goodman Corey S bought $4,999,999 worth of shares (3,184,713 units at $1.57) (SEC Form 4)

    4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)

    2/4/26 4:15:59 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fairmount Funds Management Llc bought $18,237,600 worth of Ordinary Shares (1,360,000 units at $13.41) (SEC Form 4)

    4 - CRESCENT BIOPHARMA, INC. (0001253689) (Issuer)

    12/8/25 4:30:15 PM ET
    $CBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALXO
    $AMAM
    $AXDX
    $BROG
    Leadership Updates

    Live Leadership Updates

    View All

    Douglas Cifu and Kenneth Schiciano Elected to MarketAxess Board of Directors

    MarketAxess Holdings Inc. (NASDAQ:MKTX), the operator of a leading electronic trading platform for fixed-income securities, today announced the election of Douglas Cifu and Kenneth Schiciano to serve on the Company's Board of Directors, effective March 1, 2026. Mr. Cifu is the co‑founder of Virtu Financial, a global financial technology firm and market maker. He served as President from the company's founding in 2008 until 2013, and then as Chief Executive Officer from 2013 through July 2025. He continued to advise Virtu through December 31, 2025. Before founding Virtu, Mr. Cifu was a partner at the international law firm Paul, Weiss, Rifkind, Wharton & Garrison. Mr. Schiciano has serve

    1/26/26 6:30:00 AM ET
    $MKTX
    Investment Bankers/Brokers/Service
    Finance

    Illumina Appoints Dr. Eric Green as Chief Medical Officer

    Veteran genomics leader joins Illumina to advance global medical strategyIllumina chief commercial officer to depart for role as a life science tools company CEO  SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Today, Illumina, Inc. (NASDAQ:ILMN) announced the appointment of Eric D. Green, M.D., Ph.D., as Chief Medical Officer (CMO), effective February 2. In this role reporting to the CEO, Dr. Green will accelerate the company's mission to drive a revolution in medicine by unlocking the power of the genome. Dr. Green will serve as a key scientific and medical leader representing Illumina, helping advance the clinical use of genomics, expand access to precision medicine solutions, and increase the di

    1/8/26 4:30:00 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

    Planned Leadership Transition Positions Company for Growth Company Expects to Exceed Revenue and Cash Guidance for the Full Year 2025 Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its Board of Directors (the "Board") has appointed Everett Cunningham as the Company's next President and Chief Executive Officer and a member of the Board, effective January 19, 2026. Mr. Cunningham will succeed Masoud Toloue, who will continue to serve as Chief Executive Officer until Mr. Cunningham assumes the role on January 19, 2026. Following Mr. Cunningham

    1/8/26 4:30:00 PM ET
    $ARVN
    $DGX
    $EXAS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities
    Biotechnology: Laboratory Analytical Instruments

    $ALXO
    $AMAM
    $AXDX
    $BROG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by iClick Interactive Asia Group Limited

    SC 13D/A - iClick Interactive Asia Group Ltd (0001697818) (Subject)

    12/11/24 7:11:44 AM ET
    $ICLK
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Illumina Inc.

    SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

    12/6/24 10:11:24 AM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Illumina Inc.

    SC 13G - ILLUMINA, INC. (0001110803) (Subject)

    12/5/24 7:27:01 PM ET
    $ILMN
    Medical Specialities
    Health Care

    $ALXO
    $AMAM
    $AXDX
    $BROG
    Financials

    Live finance-specific insights

    View All

    MarketAxess Reports Fourth Quarter and Full Year 2025 Financial Results

    Record Revenue of $846 Million in 2025 Driven by 10% Growth in Revenue Outside U.S. Credit Products 24% Increase in Block Trading ADV to Record $5 Billion in 2025 48% Increase in Portfolio Trading ADV to Record $1.4 Billion in 2025 with Record U.S. Credit ADV & Market Share 33% Increase in Dealer-Initiated ADV in 2025 MarketAxess Holdings Inc. (NASDAQ:MKTX), the operator of a leading electronic trading platform for fixed-income securities, today announced financial results for the fourth quarter and full year ended December 31, 2025. 4Q25 select financial and operational highlights* Total revenues of $209.4 million increased 3.5%, and included an increase of approximately $1.6

    2/6/26 6:30:00 AM ET
    $MKTX
    Investment Bankers/Brokers/Service
    Finance

    Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025

    Fourth quarter 2025 results: Revenue of $1.16 billion, up 5% from Q4 2024 (up 4% on a constant currency basis)Ex-China revenue of $1.10 billion, up 8% from Q4 2024 (up 7% on a constant currency basis)GAAP operating margin of 17.4% and non-GAAP operating margin of 23.7%GAAP diluted EPS of $2.16 and non-GAAP diluted EPS of $1.35Fiscal year 2025 results: Revenue of $4.34 billion, flat compared to 2024 on both a reported and constant currency basisEx-China revenue of $4.10 billion, up 2% from 2024 on both a reported and constant currency basisGAAP operating margin of 18.6% and non-GAAP operating margin of 23.1%GAAP diluted EPS of $5.45 and non-GAAP diluted EPS of $4.84Fiscal year 2026 guidance:

    2/5/26 4:06:00 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Ribbon Communications Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

    Strong Cash Flow and Bookings from Expanding Voice Modernization Customer Base U.S. Tier 1 Service Provider Sales up over 25% in 2025 Delays in Customer Projects and Budget Timing Impacted 4Q Results Targeting Expansion in High Growth AI and Defense Markets New Tax Benefit Expected to Result in Improved Cash Conversion PLANO, Texas, Feb. 5, 2026 /PRNewswire/ -- Ribbon Communications Inc. (NASDAQ:RBBN), a global leader in real-time communications technology and IP optical networking solutions, today announced its financial results for the fourth quarter and the full year of 2025. Ribbon Communications is dedicated to assisting the world's largest service providers, enterprises, and critical i

    2/5/26 4:03:00 PM ET
    $RBBN
    EDP Services
    Technology